Apr 19, 2024

Featuring perspectives from Dr Bradley J Monk and Dr David M O’Malley, including the following topics.

• Introduction (0:00)
• Ovarian Cancer; Role of HER2-Directed Therapy in Gynecologic Cancers — Dr O’Malley (4:36)
• Endometrial Cancer and Cervical Cancer — Dr Monk (27:59)

CME information and select...

Apr 17, 2024

Featuring perspectives from Dr Joyce F Liu, Dr Mansoor Raza Mirza and Dr David M O’Malley, moderated by Dr Kathleen N Moore, including the following topics:

• Introduction (0:00)
• Current Up-Front Treatment for Advanced Ovarian Cancer (OC) — Dr Liu (2:06)
• Potential Role of Immunotherapeutic Strategies for Advanced OC...

Feb 16, 2024

Featuring perspectives from Dr Bradley J Monk, including the following topics:

• Introduction (0:00)
• Case: A woman (gBRCA1) in her late 40s, 5 months after surgery and adjuvant paclitaxel/carboplatin for Stage II ovarian cancer, now with a single umbilical metastasis — Kellie E Schneider, MD (9:47)
• Case: A woman...

Jan 24, 2024

Featuring perspectives from Dr Antonio González-Martín, including the following topics:

• Introduction: Treatment-Related Second Cancers (0:00)
• Case: A woman in her mid 40s (gBRCA) who presents with ascites and is diagnosed with high-grade serous ovarian cancer (HGSOC) with extensive peritoneal disease — Lyndsay J...

Dec 20, 2023

Featuring an interview with Dr David M O’Malley, including the following topics:

• Prevalence of HER2 positivity among various gynecologic cancer subtypes; current testing recommendations (0:00)
• Trastuzumab and other HER2-targeted therapies as a component of treatment for HER2-positive gynecologic cancers (15:17)
• Key...